Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma.
Saved in:
| Title: | Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma. |
|---|---|
| Authors: | Ehinger, Erik1,2 (AUTHOR) erik.ehinger@med.lu.se, Kopecky, Jan2 (AUTHOR), Darabi, Anna2 (AUTHOR), Visse, Edward2 (AUTHOR), Edvardsson, Charlotte1 (AUTHOR), Tomasevic, Gregor1 (AUTHOR), Cederberg, David1 (AUTHOR), Belting, Mattias3,4,5 (AUTHOR), Bengzon, Johan1,6 (AUTHOR), Siesjö, Peter1,2 (AUTHOR) |
| Source: | BMC Neurology. 2/18/2023, Vol. 23 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 161959127 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ehinger%2C+Erik%22">Ehinger, Erik</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> erik.ehinger@med.lu.se</i><br /><searchLink fieldCode="AR" term="%22Kopecky%2C+Jan%22">Kopecky, Jan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Darabi%2C+Anna%22">Darabi, Anna</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Visse%2C+Edward%22">Visse, Edward</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Edvardsson%2C+Charlotte%22">Edvardsson, Charlotte</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tomasevic%2C+Gregor%22">Tomasevic, Gregor</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cederberg%2C+David%22">Cederberg, David</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Belting%2C+Mattias%22">Belting, Mattias</searchLink><relatesTo>3,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bengzon%2C+Johan%22">Bengzon, Johan</searchLink><relatesTo>1,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siesjö%2C+Peter%22">Siesjö, Peter</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Neurology%22">BMC Neurology</searchLink>. 2/18/2023, Vol. 23 Issue 1, p1-10. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=161959127 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12883-023-03119-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Titles: – TitleFull: Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ehinger, Erik – PersonEntity: Name: NameFull: Kopecky, Jan – PersonEntity: Name: NameFull: Darabi, Anna – PersonEntity: Name: NameFull: Visse, Edward – PersonEntity: Name: NameFull: Edvardsson, Charlotte – PersonEntity: Name: NameFull: Tomasevic, Gregor – PersonEntity: Name: NameFull: Cederberg, David – PersonEntity: Name: NameFull: Belting, Mattias – PersonEntity: Name: NameFull: Bengzon, Johan – PersonEntity: Name: NameFull: Siesjö, Peter IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 02 Text: 2/18/2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 14712377 Numbering: – Type: volume Value: 23 – Type: issue Value: 1 Titles: – TitleFull: BMC Neurology Type: main |
| ResultId | 1 |